Introduction to new oral anticoagulants (NOAC's)

Rohan Jayasinghe*, Ryan Markha, Kais Hyasat, Geoff Adsett

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


To produce a high quality article for physicians that reviews the current literature pertaining to NOAC's, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC's to be sound and have results that can be translated into clinical practice.

Original languageEnglish
Pages (from-to)7-10
Number of pages4
JournalCardiology (Pakistan)
Issue number1
Publication statusPublished - 2014
Externally publishedYes


  • NOAC's
  • Physicians
  • Potential
  • Pubmed databases
  • Rivaroxaban


Dive into the research topics of 'Introduction to new oral anticoagulants (NOAC's)'. Together they form a unique fingerprint.

Cite this